Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Lee Karras takes over the chief exec role; Barry Lederman to lead financial ops
August 27, 2015
By: Tim Wright
Editor-in-Chief, Contract Pharma
CDMO Halo Pharmaceutical has appointed Lee Karras as its chief executive officer. Mr. Karras is an established pharmaceutical business executive with over twenty-five years of healthcare industry related experience. Prior to joining Halo, he held executive leadership roles in several businesses. Most recently he was president of IBA Molecular North America, a manufacturer and distributer of radiopharmaceuticals. Mr. Karras has a proven track record of building scalable, yet cost effective businesses as well as managing complex contract research, manufacturing and pharmaceutical services businesses. Having worked in the contract pharmaceutical services industry over the last two decades, Mr. Karras has had to adapt and develop new business models to keep pace with the ever-changing pharmaceutical landscape. Halo also named Barry Lederman as its chief financial officer. Mr. Lederman has extensive financial and international pharmaceutical experience, having led teams of several public and private companies with global operations. Prior to joining Halo, he served as the vice president and chief financial officer for Eisai Inc. with operations in the Americas Region, the chief financial officer at Wedgewood Pharmacy, Nycomed US Inc., and Qualitrol Company LLC, a subsidiary of Danaher Corporation. He also spent 10 years with Roche in positions of increasing responsibility within finance, culminating in his appointment as senior vice president, head of business analysis and controlling at Roche Centralized Diagnostics, headquartered in Mannheim, Germany. “Lee and Barry have proven track records of growing and improving companies in the pharmaceutical and CDMO sector,” said Aaron Davenport, chairman, Halo Pharmaceutical, and managing director, SK Capital, Halo’s majority owner. “Lee led a pharmaceutical manufacturing business for SK Capital for the past several years with tremendous success, and is ideally suited for taking Halo from a smaller CDMO to a top-tier industry player. Similarly, Barry’s experience in acquisitions, team building and system and process improvement are perfect for Halo. Together they will provide Halo with exceptional leadership and ensure that Halo’s customers receive best-in-class service and quality.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !